After finishing at $12.04 in the prior trading day, Inovio Pharmaceuticals Inc (NASDAQ: INO) closed at $11.51, down -4.40%. In other words, the price has decreased by -$0.53 from its previous closing price. On the day, 597207 shares were traded. INO stock price reached its highest trading level at $12.02 during the session, while it also had its lowest trading level at $10.90.
Ratios:
Our goal is to gain a better understanding of INO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.60. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.09.
BofA Securities Downgraded its Neutral to Underperform on November 01, 2022, while the target price for the stock was maintained at $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 05 ’23 when Zoth Lota S. sold 5,700 shares for $0.56 per share. The transaction valued at 3,192 led to the insider holds 52,716 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INO now has a Market Capitalization of 268.99M and an Enterprise Value of 153.91M. For the stock, the TTM Price-to-Sale (P/S) ratio is 324.08 while its Price-to-Book (P/B) ratio in mrq is 2.24. Its current Enterprise Value per Revenue stands at 184.98 whereas that against EBITDA is -1.18.
Stock Price History:
Over the past 52 weeks, INO has reached a high of $14.88, while it has fallen to a 52-week low of $3.89. The 50-Day Moving Average of the stock is 7.87, while the 200-Day Moving Average is calculated to be 6.00.
Shares Statistics:
The stock has traded on average 496.54K shares per day over the past 3-months and 729.82k shares per day over the last 10 days, according to various share statistics. A total of 23.37M shares are outstanding, with a floating share count of 22.98M. Insiders hold about 1.65% of the company’s shares, while institutions hold 17.93% stake in the company. Shares short for INO as of Feb 29, 2024 were 1.86M with a Short Ratio of 3.74, compared to 1.43M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.17% and a Short% of Float of 8.23%.
Earnings Estimates
Its stock is currently analyzed by 5 different market analysts. On average, analysts expect EPS of -$0.95 for the current quarter, with a high estimate of -$0.8 and a low estimate of -$1.17, while EPS last year was -$1.92. The consensus estimate for the next quarter is -$0.92, with high estimates of -$0.71 and low estimates of -$1.15.
Analysts are recommending an EPS of between -$2.73 and -$4.64 for the fiscal current year, implying an average EPS of -$3.69. EPS for the following year is -$2.89, with 4 analysts recommending between -$1.42 and -$4.41.
